Robust evidence is available that correlates B2M variations and immune escape in CRC (Grasso et al. 2018; Ozcan et al. 2018), and this gene also acts as a driver in diffuse large B cell lymphoma (DLBC) (Fan et al. 2020). This evidence concerns the gene B2M and colorectal carcinoma.